Approvals/TGA/CSL US ZEMAIRA human alpha1-proteinase inhibitor 1000 mg powder for injection vial with diluent vial

Approved

STANDARD

CSL US ZEMAIRA human alpha1-proteinase inhibitor 1000 mg powder for injection vial with diluent vial

CSL Behring (Australia) Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 76ba5d54a4b5837e
Product Name: CSL US ZEMAIRA human alpha1-proteinase inhibitor 1000 mg powder for injection vial with diluent vial
Artg Id: 356861
Artg Name: CSL US ZEMAIRA human alpha1-proteinase inhibitor 1000 mg powder for injection vial with diluent vial
Sponsor: CSL Behring (Australia) Pty Ltd
Company Detail Path: /organization/csl-behring-australia-pty-ltd
Artg Date: 2021-03-16
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: LIE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

76ba5d54a4b5837e

Type

Standard